Wednesday, January 7: Status Update - I'm an Eighteen-Wheeler
This morning I had my appointment with my oncologist at Magee, and we agreed that my new treatment plan will follow Dr. Gershenson's recommendation of fulvestrant + ribociclib. Now we wait for insurance approvals, and then I can begin. My doctor seemed optimistic about getting the approvals, not least because a clinical trial has been studying this very combo for my cancer type. It can't be said loudly enough: Anyone who continues to support and vote republican is actively and directly harming my treatment possibilities and future options for life-saving care. Research funding and clinical trials matter. I am literally impacted by existing and future trials. My ability to get insurance approval for my new treatment, which, without approval, will cost more than $20,000 per month just for the ribociclib, relies on current clinical trials. I'm not sure it's clear to people who aren't very politically engaged that the impact this administration is having on science and ...